Novo Nordisk A/S Class B
No hay operaciones
No hay operaciones
Títulos de deuda corporativa
A continuación se muestra la lista de bonos de Novo Nordisk A/S Class B, ordenados por rendimiento mínimo. Los inversores suelen optar por los bonos de una empresa por su mayor estabilidad en periodos de volatilidad del mercado. Analice los precios, rendimientos y demás estadísticas para identificar una inversión segura.
Símbolo | YTW % | Precio % | Cupón % | Fecha de vto. | Imp. pendiente | Valor nominal | Calificación S&P | Calificación de Fitch | Calificación de Moody's | Emisor |
|---|---|---|---|---|---|---|---|---|---|---|
 XS323295972Novo Nordisk Finance (Netherlands) BV 4.0% 20-NOV-2045 | 4,72% | 91,07% | 4,000% | 2045-11-20 | 750 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS323295590Novo Nordisk Finance (Netherlands) BV 3.625% 20-FEB-2038 | 4,40% | 93,13% | 3,625% | 2038-02-20 | 750 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS300255582Novo Nordisk Finance (Netherlands) BV 3.625% 27-MAY-2037 | 4,29% | 94,37% | 3,625% | 2037-05-27 | 1,25 B EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS323294453Novo Nordisk Finance (Netherlands) BV 3.375% 20-FEB-2035 | 4,19% | 94,32% | 3,375% | 2035-02-20 | 600 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS282046075Novo Nordisk Finance (Netherlands) BV 3.375% 21-MAY-2034 | 4,09% | 95,35% | 3,375% | 2034-05-21 | 1,35 B EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS300255353Novo Nordisk Finance (Netherlands) BV 3.125% 27-MAY-2033 | 4,04% | 94,75% | 3,125% | 2033-05-27 | 900 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS323293716Novo Nordisk Finance (Netherlands) BV 3.0% 20-FEB-2032 | 3,94% | 95,55% | 3,000% | 2032-02-20 | 600 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS282045567Novo Nordisk Finance (Netherlands) BV 3.25% 21-JAN-2031 | 3,80% | 97,84% | 3,250% | 2031-01-21 | 1 B EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS300255329Novo Nordisk Finance (Netherlands) BV 2.875% 27-AUG-2030 | 3,77% | 96,81% | 2,875% | 2030-08-27 | 1 B EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS244124704Novo Nordisk Finance (Netherlands) BV 1.375% 31-MAR-2030 | 3,59% | 92,91% | 1,375% | 2030-03-31 | 500 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS323292124Novo Nordisk Finance (Netherlands) BV 2.5% 20-FEB-2029 | 3,59% | 97,57% | 2,500% | 2029-02-20 | 650 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS282045460Novo Nordisk Finance (Netherlands) BV 3.125% 21-JAN-2029 | 3,56% | 99,05% | 3,125% | 2029-01-21 | 1 B EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS234803042Novo Nordisk Finance (Netherlands) BV 0.125% 04-JUN-2028 | 3,54% | 94,66% | 0,125% | 2028-06-04 | 650 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS300255299Novo Nordisk Finance (Netherlands) BV 2.375% 27-MAY-2028 | 3,53% | 98,20% | 2,375% | 2028-05-27 | 1,45 B EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS244933017Novo Nordisk Finance (Netherlands) BV 1.125% 30-SEP-2027 | 3,22% | 98,05% | 1,125% | 2027-09-30 | 500 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
 NNO263Novo Nordisk A/S 1.6325% 11-JUN-2041 | 1,67% | 99,45% | 1,633% | 2041-06-11 | 175 M CHF | 100.000,00 CHF | AA | — | — | Novo Nordisk A/S |
| XS300255213Novo Nordisk Finance (Netherlands) BV FRN 27-MAY-2027 | — | 99,98% | 2,845% | 2027-05-27 | 1,4 B EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |
| XS323292027Novo Nordisk Finance (Netherlands) BV FRN 20-NOV-2027 | — | 99,90% | 2,700% | 2027-11-20 | 650 M EUR | 1.000,00 EUR | AA | — | — | Novo Nordisk Finance (Netherlands) BV |